Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

NCT05660473 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Cyclophosphamide
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Cytarabine
DRUG: 6-mercaptopurine
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Venetoclax

Sponsor

Institute of Hematology & Blood Diseases Hospital, China